nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—RRM2—Hydroxyurea—brain cancer	0.336	0.481	CbGbCtD
Cladribine—RRM1—Hydroxyurea—brain cancer	0.336	0.481	CbGbCtD
Cladribine—ABCG2—Carboplatin—brain cancer	0.0145	0.0207	CbGbCtD
Cladribine—ABCG2—Etoposide—brain cancer	0.0122	0.0174	CbGbCtD
Cladribine—RRM2B—ganglion—brain cancer	0.0038	0.0552	CbGeAlD
Cladribine—NR5A1—hindbrain—brain cancer	0.00264	0.0384	CbGeAlD
Cladribine—POLE2—Teniposide—Etoposide—brain cancer	0.00226	1	CbGdCrCtD
Cladribine—POLE4—endocrine gland—brain cancer	0.0018	0.0262	CbGeAlD
Cladribine—POLE4—head—brain cancer	0.00178	0.0259	CbGeAlD
Cladribine—POLE4—central nervous system—brain cancer	0.00162	0.0236	CbGeAlD
Cladribine—Azacitidine—DNMT1—brain cancer	0.00162	0.506	CrCbGaD
Cladribine—Decitabine—DNMT1—brain cancer	0.00158	0.494	CrCbGaD
Cladribine—NR5A1—brainstem—brain cancer	0.00151	0.022	CbGeAlD
Cladribine—RRM2B—telencephalon—brain cancer	0.00147	0.0213	CbGeAlD
Cladribine—POLE3—telencephalon—brain cancer	0.00139	0.0201	CbGeAlD
Cladribine—POLE4—brain—brain cancer	0.00129	0.0187	CbGeAlD
Cladribine—SLC22A1—ganglion—brain cancer	0.00124	0.0181	CbGeAlD
Cladribine—RRM2B—pituitary gland—brain cancer	0.00119	0.0174	CbGeAlD
Cladribine—POLE3—gonad—brain cancer	0.00116	0.0168	CbGeAlD
Cladribine—RRM2B—medulla oblongata—brain cancer	0.00115	0.0167	CbGeAlD
Cladribine—POLE3—pituitary gland—brain cancer	0.00113	0.0164	CbGeAlD
Cladribine—NR5A1—gonad—brain cancer	0.00112	0.0163	CbGeAlD
Cladribine—NR5A1—pituitary gland—brain cancer	0.00109	0.0159	CbGeAlD
Cladribine—POLE3—medulla oblongata—brain cancer	0.00109	0.0158	CbGeAlD
Cladribine—RRM2B—midbrain—brain cancer	0.00105	0.0153	CbGeAlD
Cladribine—RRM2B—spinal cord—brain cancer	0.00103	0.0149	CbGeAlD
Cladribine—PNP—endocrine gland—brain cancer	0.000996	0.0145	CbGeAlD
Cladribine—POLE3—midbrain—brain cancer	0.000995	0.0145	CbGeAlD
Cladribine—PNP—head—brain cancer	0.000983	0.0143	CbGeAlD
Cladribine—POLE3—spinal cord—brain cancer	0.000971	0.0141	CbGeAlD
Cladribine—RRM2B—endocrine gland—brain cancer	0.000925	0.0134	CbGeAlD
Cladribine—RRM2B—head—brain cancer	0.000913	0.0133	CbGeAlD
Cladribine—PNP—central nervous system—brain cancer	0.000898	0.013	CbGeAlD
Cladribine—POLE—gonad—brain cancer	0.000882	0.0128	CbGeAlD
Cladribine—POLE3—endocrine gland—brain cancer	0.000874	0.0127	CbGeAlD
Cladribine—POLE3—head—brain cancer	0.000863	0.0125	CbGeAlD
Cladribine—POLE—pituitary gland—brain cancer	0.000861	0.0125	CbGeAlD
Cladribine—NR5A1—endocrine gland—brain cancer	0.000847	0.0123	CbGeAlD
Cladribine—NR5A1—head—brain cancer	0.000836	0.0122	CbGeAlD
Cladribine—RRM2B—central nervous system—brain cancer	0.000833	0.0121	CbGeAlD
Cladribine—RRM2B—cerebellum—brain cancer	0.000814	0.0118	CbGeAlD
Cladribine—POLE3—central nervous system—brain cancer	0.000788	0.0114	CbGeAlD
Cladribine—POLE3—cerebellum—brain cancer	0.00077	0.0112	CbGeAlD
Cladribine—NR5A1—central nervous system—brain cancer	0.000763	0.0111	CbGeAlD
Cladribine—NR5A1—cerebellum—brain cancer	0.000746	0.0108	CbGeAlD
Cladribine—POLA1—pituitary gland—brain cancer	0.000742	0.0108	CbGeAlD
Cladribine—RRM2—gonad—brain cancer	0.000727	0.0106	CbGeAlD
Cladribine—RRM1—telencephalon—brain cancer	0.000723	0.0105	CbGeAlD
Cladribine—PNP—brain—brain cancer	0.000713	0.0104	CbGeAlD
Cladribine—RRM2—pituitary gland—brain cancer	0.000709	0.0103	CbGeAlD
Cladribine—POLE—endocrine gland—brain cancer	0.000667	0.00969	CbGeAlD
Cladribine—RRM2B—brain—brain cancer	0.000662	0.00962	CbGeAlD
Cladribine—POLE—head—brain cancer	0.000658	0.00957	CbGeAlD
Cladribine—POLE3—brain—brain cancer	0.000625	0.00909	CbGeAlD
Cladribine—NR5A1—brain—brain cancer	0.000606	0.00881	CbGeAlD
Cladribine—RRM1—gonad—brain cancer	0.000604	0.00877	CbGeAlD
Cladribine—POLE—central nervous system—brain cancer	0.000601	0.00873	CbGeAlD
Cladribine—RRM1—pituitary gland—brain cancer	0.000589	0.00856	CbGeAlD
Cladribine—POLE—cerebellum—brain cancer	0.000587	0.00854	CbGeAlD
Cladribine—RRM1—medulla oblongata—brain cancer	0.000568	0.00826	CbGeAlD
Cladribine—DCK—telencephalon—brain cancer	0.000562	0.00817	CbGeAlD
Cladribine—RRM2—endocrine gland—brain cancer	0.000549	0.00798	CbGeAlD
Cladribine—RRM2—head—brain cancer	0.000542	0.00788	CbGeAlD
Cladribine—RRM1—midbrain—brain cancer	0.000519	0.00755	CbGeAlD
Cladribine—RRM1—spinal cord—brain cancer	0.000507	0.00737	CbGeAlD
Cladribine—POLA1—cerebellum—brain cancer	0.000506	0.00736	CbGeAlD
Cladribine—RRM2—central nervous system—brain cancer	0.000495	0.00719	CbGeAlD
Cladribine—SLC22A1—telencephalon—brain cancer	0.000479	0.00696	CbGeAlD
Cladribine—POLE—brain—brain cancer	0.000477	0.00693	CbGeAlD
Cladribine—DCK—gonad—brain cancer	0.000469	0.00682	CbGeAlD
Cladribine—DCK—pituitary gland—brain cancer	0.000457	0.00665	CbGeAlD
Cladribine—RRM1—endocrine gland—brain cancer	0.000456	0.00663	CbGeAlD
Cladribine—RRM1—head—brain cancer	0.00045	0.00655	CbGeAlD
Cladribine—DCK—medulla oblongata—brain cancer	0.000441	0.00642	CbGeAlD
Cladribine—POLA1—brain—brain cancer	0.000411	0.00598	CbGeAlD
Cladribine—RRM1—central nervous system—brain cancer	0.000411	0.00598	CbGeAlD
Cladribine—DCK—midbrain—brain cancer	0.000403	0.00586	CbGeAlD
Cladribine—RRM1—cerebellum—brain cancer	0.000402	0.00584	CbGeAlD
Cladribine—DCK—spinal cord—brain cancer	0.000394	0.00572	CbGeAlD
Cladribine—RRM2—brain—brain cancer	0.000393	0.00571	CbGeAlD
Cladribine—DCK—endocrine gland—brain cancer	0.000354	0.00515	CbGeAlD
Cladribine—DCK—head—brain cancer	0.00035	0.00508	CbGeAlD
Cladribine—RRM1—brain—brain cancer	0.000326	0.00474	CbGeAlD
Cladribine—DCK—central nervous system—brain cancer	0.000319	0.00464	CbGeAlD
Cladribine—ABCG2—telencephalon—brain cancer	0.000313	0.00456	CbGeAlD
Cladribine—DCK—cerebellum—brain cancer	0.000312	0.00454	CbGeAlD
Cladribine—SLC22A1—endocrine gland—brain cancer	0.000302	0.00439	CbGeAlD
Cladribine—SLC22A1—head—brain cancer	0.000298	0.00434	CbGeAlD
Cladribine—SLC22A1—central nervous system—brain cancer	0.000272	0.00396	CbGeAlD
Cladribine—Cough—Procarbazine—brain cancer	0.000271	0.00202	CcSEcCtD
Cladribine—Pancytopenia—Carmustine—brain cancer	0.000265	0.00198	CcSEcCtD
Cladribine—Myalgia—Procarbazine—brain cancer	0.000264	0.00197	CcSEcCtD
Cladribine—Arthralgia—Procarbazine—brain cancer	0.000264	0.00197	CcSEcCtD
Cladribine—Anxiety—Procarbazine—brain cancer	0.000264	0.00197	CcSEcCtD
Cladribine—Sweating increased—Temozolomide—brain cancer	0.000263	0.00196	CcSEcCtD
Cladribine—Neutropenia—Carmustine—brain cancer	0.000261	0.00195	CcSEcCtD
Cladribine—Pancytopenia—Temozolomide—brain cancer	0.000256	0.00191	CcSEcCtD
Cladribine—Cardiac failure—Etoposide—brain cancer	0.000256	0.00191	CcSEcCtD
Cladribine—Confusional state—Procarbazine—brain cancer	0.000256	0.00191	CcSEcCtD
Cladribine—ABCG2—pituitary gland—brain cancer	0.000255	0.00371	CbGeAlD
Cladribine—Vomiting—Lomustine—brain cancer	0.000254	0.0019	CcSEcCtD
Cladribine—DCK—brain—brain cancer	0.000254	0.00368	CbGeAlD
Cladribine—Oedema—Procarbazine—brain cancer	0.000254	0.00189	CcSEcCtD
Cladribine—Neutropenia—Temozolomide—brain cancer	0.000252	0.00188	CcSEcCtD
Cladribine—Infection—Procarbazine—brain cancer	0.000252	0.00188	CcSEcCtD
Cladribine—Angiopathy—Hydroxyurea—brain cancer	0.000251	0.00187	CcSEcCtD
Cladribine—Upper respiratory tract infection—Temozolomide—brain cancer	0.000251	0.00187	CcSEcCtD
Cladribine—Pneumonia—Carmustine—brain cancer	0.00025	0.00187	CcSEcCtD
Cladribine—Thrombocytopenia—Procarbazine—brain cancer	0.000248	0.00185	CcSEcCtD
Cladribine—Chills—Hydroxyurea—brain cancer	0.000248	0.00185	CcSEcCtD
Cladribine—Tachycardia—Procarbazine—brain cancer	0.000247	0.00185	CcSEcCtD
Cladribine—ABCG2—medulla oblongata—brain cancer	0.000246	0.00358	CbGeAlD
Cladribine—Hyperhidrosis—Procarbazine—brain cancer	0.000245	0.00183	CcSEcCtD
Cladribine—Renal failure—Carmustine—brain cancer	0.000244	0.00183	CcSEcCtD
Cladribine—Alopecia—Hydroxyurea—brain cancer	0.000244	0.00182	CcSEcCtD
Cladribine—Urinary tract infection—Carmustine—brain cancer	0.000242	0.00181	CcSEcCtD
Cladribine—Pneumonia—Temozolomide—brain cancer	0.000242	0.00181	CcSEcCtD
Cladribine—Anorexia—Procarbazine—brain cancer	0.000242	0.0018	CcSEcCtD
Cladribine—Erythema—Hydroxyurea—brain cancer	0.00024	0.0018	CcSEcCtD
Cladribine—Infestation NOS—Temozolomide—brain cancer	0.00024	0.00179	CcSEcCtD
Cladribine—Infestation—Temozolomide—brain cancer	0.00024	0.00179	CcSEcCtD
Cladribine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000238	0.00178	CcSEcCtD
Cladribine—Nausea—Lomustine—brain cancer	0.000237	0.00177	CcSEcCtD
Cladribine—Hypotension—Procarbazine—brain cancer	0.000237	0.00177	CcSEcCtD
Cladribine—Urinary tract infection—Temozolomide—brain cancer	0.000234	0.00174	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000231	0.00172	CcSEcCtD
Cladribine—Insomnia—Procarbazine—brain cancer	0.000229	0.00171	CcSEcCtD
Cladribine—Paraesthesia—Procarbazine—brain cancer	0.000228	0.0017	CcSEcCtD
Cladribine—Hepatobiliary disease—Temozolomide—brain cancer	0.000227	0.0017	CcSEcCtD
Cladribine—Somnolence—Procarbazine—brain cancer	0.000225	0.00168	CcSEcCtD
Cladribine—ABCG2—midbrain—brain cancer	0.000225	0.00327	CbGeAlD
Cladribine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000225	0.00168	CcSEcCtD
Cladribine—Haemoglobin—Carmustine—brain cancer	0.000224	0.00168	CcSEcCtD
Cladribine—Haemorrhage—Carmustine—brain cancer	0.000223	0.00167	CcSEcCtD
Cladribine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000223	0.00167	CcSEcCtD
Cladribine—Anaemia—Hydroxyurea—brain cancer	0.000222	0.00166	CcSEcCtD
Cladribine—Decreased appetite—Procarbazine—brain cancer	0.00022	0.00165	CcSEcCtD
Cladribine—Oedema peripheral—Carmustine—brain cancer	0.00022	0.00164	CcSEcCtD
Cladribine—ABCG2—spinal cord—brain cancer	0.00022	0.00319	CbGeAlD
Cladribine—Connective tissue disorder—Carmustine—brain cancer	0.000219	0.00164	CcSEcCtD
Cladribine—Fatigue—Procarbazine—brain cancer	0.000219	0.00163	CcSEcCtD
Cladribine—Haemoglobin—Temozolomide—brain cancer	0.000217	0.00162	CcSEcCtD
Cladribine—Malaise—Hydroxyurea—brain cancer	0.000217	0.00162	CcSEcCtD
Cladribine—Constipation—Procarbazine—brain cancer	0.000217	0.00162	CcSEcCtD
Cladribine—Pain—Procarbazine—brain cancer	0.000217	0.00162	CcSEcCtD
Cladribine—SLC22A1—brain—brain cancer	0.000216	0.00314	CbGeAlD
Cladribine—Haemorrhage—Temozolomide—brain cancer	0.000216	0.00161	CcSEcCtD
Cladribine—Pharyngitis—Temozolomide—brain cancer	0.000214	0.0016	CcSEcCtD
Cladribine—Urinary tract disorder—Temozolomide—brain cancer	0.000213	0.00159	CcSEcCtD
Cladribine—Oedema peripheral—Temozolomide—brain cancer	0.000213	0.00159	CcSEcCtD
Cladribine—Connective tissue disorder—Temozolomide—brain cancer	0.000212	0.00158	CcSEcCtD
Cladribine—Urethral disorder—Temozolomide—brain cancer	0.000211	0.00158	CcSEcCtD
Cladribine—Sweating increased—Etoposide—brain cancer	0.00021	0.00157	CcSEcCtD
Cladribine—Feeling abnormal—Procarbazine—brain cancer	0.000209	0.00156	CcSEcCtD
Cladribine—Eye disorder—Carmustine—brain cancer	0.000209	0.00156	CcSEcCtD
Cladribine—Gastrointestinal pain—Procarbazine—brain cancer	0.000207	0.00155	CcSEcCtD
Cladribine—Pancytopenia—Etoposide—brain cancer	0.000205	0.00153	CcSEcCtD
Cladribine—Erythema multiforme—Temozolomide—brain cancer	0.000204	0.00152	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000203	0.00152	CcSEcCtD
Cladribine—Discomfort—Hydroxyurea—brain cancer	0.000202	0.00151	CcSEcCtD
Cladribine—Neutropenia—Etoposide—brain cancer	0.000202	0.00151	CcSEcCtD
Cladribine—Eye disorder—Temozolomide—brain cancer	0.000202	0.00151	CcSEcCtD
Cladribine—Urticaria—Procarbazine—brain cancer	0.000201	0.0015	CcSEcCtD
Cladribine—Abdominal pain—Procarbazine—brain cancer	0.0002	0.0015	CcSEcCtD
Cladribine—Body temperature increased—Procarbazine—brain cancer	0.0002	0.0015	CcSEcCtD
Cladribine—Cardiac disorder—Temozolomide—brain cancer	0.0002	0.0015	CcSEcCtD
Cladribine—Arrhythmia—Carmustine—brain cancer	0.000199	0.00149	CcSEcCtD
Cladribine—Alopecia—Carmustine—brain cancer	0.000197	0.00147	CcSEcCtD
Cladribine—Oedema—Hydroxyurea—brain cancer	0.000196	0.00147	CcSEcCtD
Cladribine—Angiopathy—Temozolomide—brain cancer	0.000196	0.00146	CcSEcCtD
Cladribine—Mental disorder—Carmustine—brain cancer	0.000196	0.00146	CcSEcCtD
Cladribine—Infection—Hydroxyurea—brain cancer	0.000195	0.00146	CcSEcCtD
Cladribine—Immune system disorder—Temozolomide—brain cancer	0.000195	0.00146	CcSEcCtD
Cladribine—Mediastinal disorder—Temozolomide—brain cancer	0.000194	0.00145	CcSEcCtD
Cladribine—Erythema—Carmustine—brain cancer	0.000194	0.00145	CcSEcCtD
Cladribine—Malnutrition—Carmustine—brain cancer	0.000194	0.00145	CcSEcCtD
Cladribine—Chills—Temozolomide—brain cancer	0.000194	0.00145	CcSEcCtD
Cladribine—Pneumonia—Etoposide—brain cancer	0.000193	0.00144	CcSEcCtD
Cladribine—Nervous system disorder—Hydroxyurea—brain cancer	0.000192	0.00144	CcSEcCtD
Cladribine—Infestation NOS—Etoposide—brain cancer	0.000192	0.00144	CcSEcCtD
Cladribine—Infestation—Etoposide—brain cancer	0.000192	0.00144	CcSEcCtD
Cladribine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000192	0.00143	CcSEcCtD
Cladribine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000191	0.00142	CcSEcCtD
Cladribine—Alopecia—Temozolomide—brain cancer	0.000191	0.00142	CcSEcCtD
Cladribine—Skin disorder—Hydroxyurea—brain cancer	0.000191	0.00142	CcSEcCtD
Cladribine—Renal failure—Etoposide—brain cancer	0.000189	0.00141	CcSEcCtD
Cladribine—Mental disorder—Temozolomide—brain cancer	0.000189	0.00141	CcSEcCtD
Cladribine—Back pain—Carmustine—brain cancer	0.000188	0.0014	CcSEcCtD
Cladribine—Erythema—Temozolomide—brain cancer	0.000188	0.0014	CcSEcCtD
Cladribine—Malnutrition—Temozolomide—brain cancer	0.000188	0.0014	CcSEcCtD
Cladribine—Anorexia—Hydroxyurea—brain cancer	0.000187	0.0014	CcSEcCtD
Cladribine—Hypersensitivity—Procarbazine—brain cancer	0.000187	0.00139	CcSEcCtD
Cladribine—Asthenia—Procarbazine—brain cancer	0.000182	0.00136	CcSEcCtD
Cladribine—Hepatobiliary disease—Etoposide—brain cancer	0.000182	0.00136	CcSEcCtD
Cladribine—Back pain—Temozolomide—brain cancer	0.000182	0.00136	CcSEcCtD
Cladribine—RRM2—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000181	0.00196	CbGpPWpGaD
Cladribine—Anaemia—Carmustine—brain cancer	0.00018	0.00134	CcSEcCtD
Cladribine—Pruritus—Procarbazine—brain cancer	0.000179	0.00134	CcSEcCtD
Cladribine—POLE—DNA Repair—PCNA—brain cancer	0.000178	0.00192	CbGpPWpGaD
Cladribine—POLE—G1 to S cell cycle control—CDKN2A—brain cancer	0.000176	0.0019	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000176	0.0019	CbGpPWpGaD
Cladribine—Dyspnoea—Hydroxyurea—brain cancer	0.000175	0.00131	CcSEcCtD
Cladribine—Somnolence—Hydroxyurea—brain cancer	0.000174	0.0013	CcSEcCtD
Cladribine—Ill-defined disorder—Temozolomide—brain cancer	0.000174	0.0013	CcSEcCtD
Cladribine—POLE—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000174	0.00188	CbGpPWpGaD
Cladribine—ABCG2—cerebellum—brain cancer	0.000174	0.00253	CbGeAlD
Cladribine—RRM2—E2F transcription factor network—CDKN2A—brain cancer	0.000174	0.00187	CbGpPWpGaD
Cladribine—Anaemia—Temozolomide—brain cancer	0.000174	0.0013	CcSEcCtD
Cladribine—Diarrhoea—Procarbazine—brain cancer	0.000173	0.0013	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000172	0.00186	CbGpPWpGaD
Cladribine—Decreased appetite—Hydroxyurea—brain cancer	0.000171	0.00127	CcSEcCtD
Cladribine—POLA1—Telomere Maintenance—PCNA—brain cancer	0.000171	0.00184	CbGpPWpGaD
Cladribine—Urinary tract disorder—Etoposide—brain cancer	0.00017	0.00127	CcSEcCtD
Cladribine—RRM2B—Metabolism—CYP2C9—brain cancer	0.00017	0.00183	CbGpPWpGaD
Cladribine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000169	0.00126	CcSEcCtD
Cladribine—Malaise—Temozolomide—brain cancer	0.000169	0.00126	CcSEcCtD
Cladribine—Urethral disorder—Etoposide—brain cancer	0.000169	0.00126	CcSEcCtD
Cladribine—Fatigue—Hydroxyurea—brain cancer	0.000169	0.00126	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000169	0.00182	CbGpPWpGaD
Cladribine—Constipation—Hydroxyurea—brain cancer	0.000168	0.00125	CcSEcCtD
Cladribine—Pain—Hydroxyurea—brain cancer	0.000168	0.00125	CcSEcCtD
Cladribine—Dizziness—Procarbazine—brain cancer	0.000168	0.00125	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000167	0.0018	CbGpPWpGaD
Cladribine—RRM2B—Direct p53 effectors—EGFR—brain cancer	0.000167	0.0018	CbGpPWpGaD
Cladribine—POLE—S Phase—PCNA—brain cancer	0.000166	0.00179	CbGpPWpGaD
Cladribine—Myalgia—Carmustine—brain cancer	0.000165	0.00124	CcSEcCtD
Cladribine—Chest pain—Carmustine—brain cancer	0.000165	0.00124	CcSEcCtD
Cladribine—Anxiety—Carmustine—brain cancer	0.000165	0.00123	CcSEcCtD
Cladribine—POLA1—Mitotic G1-G1/S phases—CDK6—brain cancer	0.000165	0.00178	CbGpPWpGaD
Cladribine—Cough—Temozolomide—brain cancer	0.000164	0.00122	CcSEcCtD
Cladribine—Erythema multiforme—Etoposide—brain cancer	0.000163	0.00122	CcSEcCtD
Cladribine—Feeling abnormal—Hydroxyurea—brain cancer	0.000162	0.00121	CcSEcCtD
Cladribine—Eye disorder—Etoposide—brain cancer	0.000161	0.0012	CcSEcCtD
Cladribine—Vomiting—Procarbazine—brain cancer	0.000161	0.0012	CcSEcCtD
Cladribine—RRM2—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000161	0.00173	CbGpPWpGaD
Cladribine—Cardiac disorder—Etoposide—brain cancer	0.00016	0.0012	CcSEcCtD
Cladribine—Confusional state—Carmustine—brain cancer	0.00016	0.00119	CcSEcCtD
Cladribine—Arthralgia—Temozolomide—brain cancer	0.00016	0.00119	CcSEcCtD
Cladribine—Myalgia—Temozolomide—brain cancer	0.00016	0.00119	CcSEcCtD
Cladribine—Rash—Procarbazine—brain cancer	0.00016	0.00119	CcSEcCtD
Cladribine—Dermatitis—Procarbazine—brain cancer	0.00016	0.00119	CcSEcCtD
Cladribine—Anxiety—Temozolomide—brain cancer	0.000159	0.00119	CcSEcCtD
Cladribine—Headache—Procarbazine—brain cancer	0.000159	0.00119	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000159	0.00119	CcSEcCtD
Cladribine—Oedema—Carmustine—brain cancer	0.000159	0.00118	CcSEcCtD
Cladribine—POLE2—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000158	0.00171	CbGpPWpGaD
Cladribine—Discomfort—Temozolomide—brain cancer	0.000158	0.00118	CcSEcCtD
Cladribine—Infection—Carmustine—brain cancer	0.000158	0.00118	CcSEcCtD
Cladribine—Angiopathy—Etoposide—brain cancer	0.000157	0.00117	CcSEcCtD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000156	0.00169	CbGpPWpGaD
Cladribine—Immune system disorder—Etoposide—brain cancer	0.000156	0.00116	CcSEcCtD
Cladribine—Mediastinal disorder—Etoposide—brain cancer	0.000156	0.00116	CcSEcCtD
Cladribine—Thrombocytopenia—Carmustine—brain cancer	0.000155	0.00116	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000155	0.00167	CbGpPWpGaD
Cladribine—Body temperature increased—Hydroxyurea—brain cancer	0.000155	0.00116	CcSEcCtD
Cladribine—Chills—Etoposide—brain cancer	0.000155	0.00116	CcSEcCtD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000155	0.00167	CbGpPWpGaD
Cladribine—Tachycardia—Carmustine—brain cancer	0.000155	0.00116	CcSEcCtD
Cladribine—Confusional state—Temozolomide—brain cancer	0.000155	0.00115	CcSEcCtD
Cladribine—POLE—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000154	0.00166	CbGpPWpGaD
Cladribine—Oedema—Temozolomide—brain cancer	0.000153	0.00114	CcSEcCtD
Cladribine—NR5A1—Developmental Biology—TRPC6—brain cancer	0.000153	0.00165	CbGpPWpGaD
Cladribine—Alopecia—Etoposide—brain cancer	0.000153	0.00114	CcSEcCtD
Cladribine—POLE2—G1 to S cell cycle control—TP53—brain cancer	0.000152	0.00164	CbGpPWpGaD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000152	0.00164	CbGpPWpGaD
Cladribine—Infection—Temozolomide—brain cancer	0.000152	0.00114	CcSEcCtD
Cladribine—Anorexia—Carmustine—brain cancer	0.000151	0.00113	CcSEcCtD
Cladribine—Nausea—Procarbazine—brain cancer	0.000151	0.00112	CcSEcCtD
Cladribine—Nervous system disorder—Temozolomide—brain cancer	0.00015	0.00112	CcSEcCtD
Cladribine—Thrombocytopenia—Temozolomide—brain cancer	0.00015	0.00112	CcSEcCtD
Cladribine—POLA1—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000149	0.00161	CbGpPWpGaD
Cladribine—POLE—G1 to S cell cycle control—CCND1—brain cancer	0.000149	0.00161	CbGpPWpGaD
Cladribine—Skin disorder—Temozolomide—brain cancer	0.000149	0.00111	CcSEcCtD
Cladribine—Hypotension—Carmustine—brain cancer	0.000148	0.00111	CcSEcCtD
Cladribine—Hyperhidrosis—Temozolomide—brain cancer	0.000148	0.00111	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000148	0.00159	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000148	0.00159	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—SKP2—brain cancer	0.000148	0.00159	CbGpPWpGaD
Cladribine—POLA1—G1/S Transition—CCNE1—brain cancer	0.000147	0.00159	CbGpPWpGaD
Cladribine—PNP—Metabolism—CYP2C9—brain cancer	0.000147	0.00158	CbGpPWpGaD
Cladribine—Anorexia—Temozolomide—brain cancer	0.000146	0.00109	CcSEcCtD
Cladribine—Back pain—Etoposide—brain cancer	0.000145	0.00109	CcSEcCtD
Cladribine—Hypersensitivity—Hydroxyurea—brain cancer	0.000145	0.00108	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000145	0.00108	CcSEcCtD
Cladribine—POLA1—Synthesis of DNA—PCNA—brain cancer	0.000144	0.00156	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—BSG—brain cancer	0.000144	0.00155	CbGpPWpGaD
Cladribine—POLE2—S Phase—CCND1—brain cancer	0.000144	0.00155	CbGpPWpGaD
Cladribine—POLE—S Phase—CDK4—brain cancer	0.000144	0.00155	CbGpPWpGaD
Cladribine—Insomnia—Carmustine—brain cancer	0.000143	0.00107	CcSEcCtD
Cladribine—RRM1—E2F transcription factor network—MYC—brain cancer	0.000143	0.00154	CbGpPWpGaD
Cladribine—Paraesthesia—Carmustine—brain cancer	0.000142	0.00106	CcSEcCtD
Cladribine—POLA1—Chromosome Maintenance—PCNA—brain cancer	0.000142	0.00153	CbGpPWpGaD
Cladribine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000142	0.00153	CbGpPWpGaD
Cladribine—ABCG2—brain—brain cancer	0.000141	0.00206	CbGeAlD
Cladribine—Dyspnoea—Carmustine—brain cancer	0.000141	0.00106	CcSEcCtD
Cladribine—Somnolence—Carmustine—brain cancer	0.000141	0.00105	CcSEcCtD
Cladribine—Asthenia—Hydroxyurea—brain cancer	0.000141	0.00105	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00014	0.00151	CbGpPWpGaD
Cladribine—RRM2B—Direct p53 effectors—TP53—brain cancer	0.00014	0.00151	CbGpPWpGaD
Cladribine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00014	0.00104	CcSEcCtD
Cladribine—Ill-defined disorder—Etoposide—brain cancer	0.000139	0.00104	CcSEcCtD
Cladribine—RRM2—Mitotic G1-G1/S phases—CDK4—brain cancer	0.000139	0.0015	CbGpPWpGaD
Cladribine—Anaemia—Etoposide—brain cancer	0.000139	0.00104	CcSEcCtD
Cladribine—Insomnia—Temozolomide—brain cancer	0.000139	0.00104	CcSEcCtD
Cladribine—Decreased appetite—Carmustine—brain cancer	0.000138	0.00103	CcSEcCtD
Cladribine—Paraesthesia—Temozolomide—brain cancer	0.000138	0.00103	CcSEcCtD
Cladribine—Gastrointestinal disorder—Carmustine—brain cancer	0.000137	0.00102	CcSEcCtD
Cladribine—Dyspnoea—Temozolomide—brain cancer	0.000137	0.00102	CcSEcCtD
Cladribine—Somnolence—Temozolomide—brain cancer	0.000136	0.00102	CcSEcCtD
Cladribine—Pain—Carmustine—brain cancer	0.000136	0.00101	CcSEcCtD
Cladribine—Constipation—Carmustine—brain cancer	0.000136	0.00101	CcSEcCtD
Cladribine—Malaise—Etoposide—brain cancer	0.000136	0.00101	CcSEcCtD
Cladribine—POLA1—DNA Replication—PCNA—brain cancer	0.000135	0.00146	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000135	0.00146	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—ESR2—brain cancer	0.000135	0.00145	CbGpPWpGaD
Cladribine—Diarrhoea—Hydroxyurea—brain cancer	0.000134	0.001	CcSEcCtD
Cladribine—POLA1—S Phase—CCNE1—brain cancer	0.000134	0.00144	CbGpPWpGaD
Cladribine—POLE2—Mitotic G1-G1/S phases—CCND1—brain cancer	0.000134	0.00144	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—PPP1R12A—brain cancer	0.000134	0.00144	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—CDK4—brain cancer	0.000133	0.00144	CbGpPWpGaD
Cladribine—Decreased appetite—Temozolomide—brain cancer	0.000133	0.000995	CcSEcCtD
Cladribine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000132	0.000988	CcSEcCtD
Cladribine—Fatigue—Temozolomide—brain cancer	0.000132	0.000987	CcSEcCtD
Cladribine—POLE2—Cell Cycle—SKP2—brain cancer	0.000132	0.00142	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—CDK6—brain cancer	0.000132	0.00142	CbGpPWpGaD
Cladribine—Cough—Etoposide—brain cancer	0.000131	0.000979	CcSEcCtD
Cladribine—Constipation—Temozolomide—brain cancer	0.000131	0.000979	CcSEcCtD
Cladribine—Pain—Temozolomide—brain cancer	0.000131	0.000979	CcSEcCtD
Cladribine—Feeling abnormal—Carmustine—brain cancer	0.000131	0.000976	CcSEcCtD
Cladribine—POLA1—G1/S Transition—PCNA—brain cancer	0.00013	0.00141	CbGpPWpGaD
Cladribine—Dizziness—Hydroxyurea—brain cancer	0.00013	0.000969	CcSEcCtD
Cladribine—Gastrointestinal pain—Carmustine—brain cancer	0.00013	0.000969	CcSEcCtD
Cladribine—Chest pain—Etoposide—brain cancer	0.000128	0.000955	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000128	0.00138	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—NOTCH2—brain cancer	0.000128	0.00138	CbGpPWpGaD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000128	0.00138	CbGpPWpGaD
Cladribine—POLE2—G1/S Transition—MYC—brain cancer	0.000127	0.00137	CbGpPWpGaD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000127	0.000949	CcSEcCtD
Cladribine—Discomfort—Etoposide—brain cancer	0.000126	0.000944	CcSEcCtD
Cladribine—Feeling abnormal—Temozolomide—brain cancer	0.000126	0.000943	CcSEcCtD
Cladribine—Body temperature increased—Carmustine—brain cancer	0.000125	0.000936	CcSEcCtD
Cladribine—Abdominal pain—Carmustine—brain cancer	0.000125	0.000936	CcSEcCtD
Cladribine—Gastrointestinal pain—Temozolomide—brain cancer	0.000125	0.000936	CcSEcCtD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000125	0.00135	CbGpPWpGaD
Cladribine—PNP—Metabolism—BSG—brain cancer	0.000125	0.00135	CbGpPWpGaD
Cladribine—Vomiting—Hydroxyurea—brain cancer	0.000125	0.000932	CcSEcCtD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000124	0.00134	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000124	0.00134	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—IDH1—brain cancer	0.000124	0.00134	CbGpPWpGaD
Cladribine—Rash—Hydroxyurea—brain cancer	0.000124	0.000924	CcSEcCtD
Cladribine—Confusional state—Etoposide—brain cancer	0.000124	0.000924	CcSEcCtD
Cladribine—Dermatitis—Hydroxyurea—brain cancer	0.000124	0.000923	CcSEcCtD
Cladribine—SLC28A3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000123	0.00133	CbGpPWpGaD
Cladribine—Headache—Hydroxyurea—brain cancer	0.000123	0.000918	CcSEcCtD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000122	0.00132	CbGpPWpGaD
Cladribine—Infection—Etoposide—brain cancer	0.000122	0.00091	CcSEcCtD
Cladribine—Urticaria—Temozolomide—brain cancer	0.000122	0.000909	CcSEcCtD
Cladribine—Abdominal pain—Temozolomide—brain cancer	0.000121	0.000905	CcSEcCtD
Cladribine—Body temperature increased—Temozolomide—brain cancer	0.000121	0.000905	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.00012	0.0013	CbGpPWpGaD
Cladribine—Thrombocytopenia—Etoposide—brain cancer	0.00012	0.000897	CcSEcCtD
Cladribine—Tachycardia—Etoposide—brain cancer	0.00012	0.000894	CcSEcCtD
Cladribine—POLE—G1 to S cell cycle control—MYC—brain cancer	0.00012	0.00129	CbGpPWpGaD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000119	0.00129	CbGpPWpGaD
Cladribine—Skin disorder—Etoposide—brain cancer	0.000119	0.00089	CcSEcCtD
Cladribine—POLA1—E2F transcription factor network—CDKN2A—brain cancer	0.000119	0.00128	CbGpPWpGaD
Cladribine—Hyperhidrosis—Etoposide—brain cancer	0.000119	0.000885	CcSEcCtD
Cladribine—POLA1—S Phase—PCNA—brain cancer	0.000118	0.00128	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000118	0.00127	CbGpPWpGaD
Cladribine—RRM2—E2F transcription factor network—MYC—brain cancer	0.000118	0.00127	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDK6—brain cancer	0.000118	0.00127	CbGpPWpGaD
Cladribine—Anorexia—Etoposide—brain cancer	0.000117	0.000873	CcSEcCtD
Cladribine—Hypersensitivity—Carmustine—brain cancer	0.000117	0.000873	CcSEcCtD
Cladribine—Nausea—Hydroxyurea—brain cancer	0.000117	0.00087	CcSEcCtD
Cladribine—POLE2—S Phase—MYC—brain cancer	0.000116	0.00125	CbGpPWpGaD
Cladribine—Hypotension—Etoposide—brain cancer	0.000115	0.000856	CcSEcCtD
Cladribine—Asthenia—Carmustine—brain cancer	0.000114	0.00085	CcSEcCtD
Cladribine—Hypersensitivity—Temozolomide—brain cancer	0.000113	0.000843	CcSEcCtD
Cladribine—Paraesthesia—Etoposide—brain cancer	0.00011	0.000822	CcSEcCtD
Cladribine—Asthenia—Temozolomide—brain cancer	0.00011	0.000821	CcSEcCtD
Cladribine—POLA1—Mitotic G1-G1/S phases—PCNA—brain cancer	0.00011	0.00119	CbGpPWpGaD
Cladribine—Dyspnoea—Etoposide—brain cancer	0.000109	0.000817	CcSEcCtD
Cladribine—Somnolence—Etoposide—brain cancer	0.000109	0.000814	CcSEcCtD
Cladribine—Diarrhoea—Carmustine—brain cancer	0.000109	0.00081	CcSEcCtD
Cladribine—Pruritus—Temozolomide—brain cancer	0.000108	0.00081	CcSEcCtD
Cladribine—PNP—Metabolism—IDH1—brain cancer	0.000107	0.00116	CbGpPWpGaD
Cladribine—POLE2—Mitotic G1-G1/S phases—MYC—brain cancer	0.000107	0.00116	CbGpPWpGaD
Cladribine—Decreased appetite—Etoposide—brain cancer	0.000107	0.000796	CcSEcCtD
Cladribine—RRM2—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000106	0.00115	CbGpPWpGaD
Cladribine—Gastrointestinal disorder—Etoposide—brain cancer	0.000106	0.000791	CcSEcCtD
Cladribine—Fatigue—Etoposide—brain cancer	0.000106	0.00079	CcSEcCtD
Cladribine—Dizziness—Carmustine—brain cancer	0.000105	0.000783	CcSEcCtD
Cladribine—Constipation—Etoposide—brain cancer	0.000105	0.000783	CcSEcCtD
Cladribine—Pain—Etoposide—brain cancer	0.000105	0.000783	CcSEcCtD
Cladribine—Diarrhoea—Temozolomide—brain cancer	0.000105	0.000783	CcSEcCtD
Cladribine—POLA1—S Phase—CDK4—brain cancer	0.000102	0.0011	CbGpPWpGaD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000102	0.0011	CbGpPWpGaD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000102	0.0011	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000102	0.0011	CbGpPWpGaD
Cladribine—Dizziness—Temozolomide—brain cancer	0.000101	0.000757	CcSEcCtD
Cladribine—Feeling abnormal—Etoposide—brain cancer	0.000101	0.000755	CcSEcCtD
Cladribine—Vomiting—Carmustine—brain cancer	0.000101	0.000753	CcSEcCtD
Cladribine—Gastrointestinal pain—Etoposide—brain cancer	0.0001	0.000749	CcSEcCtD
Cladribine—Rash—Carmustine—brain cancer	0.0001	0.000747	CcSEcCtD
Cladribine—Dermatitis—Carmustine—brain cancer	9.99e-05	0.000746	CcSEcCtD
Cladribine—Headache—Carmustine—brain cancer	9.94e-05	0.000742	CcSEcCtD
Cladribine—RRM2—Cell Cycle, Mitotic—SKP2—brain cancer	9.91e-05	0.00107	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—CCNE1—brain cancer	9.91e-05	0.00107	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—HES1—brain cancer	9.86e-05	0.00106	CbGpPWpGaD
Cladribine—POLE—G1 to S cell cycle control—TP53—brain cancer	9.82e-05	0.00106	CbGpPWpGaD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—MYC—brain cancer	9.82e-05	0.00106	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—ENO2—brain cancer	9.8e-05	0.00106	CbGpPWpGaD
Cladribine—Vomiting—Temozolomide—brain cancer	9.75e-05	0.000728	CcSEcCtD
Cladribine—Urticaria—Etoposide—brain cancer	9.74e-05	0.000728	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	9.71e-05	0.00105	CbGpPWpGaD
Cladribine—Body temperature increased—Etoposide—brain cancer	9.7e-05	0.000724	CcSEcCtD
Cladribine—Abdominal pain—Etoposide—brain cancer	9.7e-05	0.000724	CcSEcCtD
Cladribine—Rash—Temozolomide—brain cancer	9.66e-05	0.000722	CcSEcCtD
Cladribine—Dermatitis—Temozolomide—brain cancer	9.66e-05	0.000721	CcSEcCtD
Cladribine—Headache—Temozolomide—brain cancer	9.6e-05	0.000717	CcSEcCtD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—MYC—brain cancer	9.56e-05	0.00103	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	9.52e-05	0.00103	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—SKP2—brain cancer	9.52e-05	0.00103	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—CDK4—brain cancer	9.51e-05	0.00102	CbGpPWpGaD
Cladribine—Nausea—Carmustine—brain cancer	9.42e-05	0.000704	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	9.4e-05	0.00101	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	9.35e-05	0.00101	CbGpPWpGaD
Cladribine—POLE—S Phase—CCND1—brain cancer	9.28e-05	0.001	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—BRCA2—brain cancer	9.15e-05	0.000987	CbGpPWpGaD
Cladribine—Nausea—Temozolomide—brain cancer	9.1e-05	0.00068	CcSEcCtD
Cladribine—Hypersensitivity—Etoposide—brain cancer	9.04e-05	0.000675	CcSEcCtD
Cladribine—RRM2—Mitotic G1-G1/S phases—CCND1—brain cancer	8.97e-05	0.000968	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—SKP2—brain cancer	8.87e-05	0.000956	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CCNE1—brain cancer	8.87e-05	0.000956	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDK6—brain cancer	8.84e-05	0.000953	CbGpPWpGaD
Cladribine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	8.82e-05	0.000951	CbGpPWpGaD
Cladribine—Asthenia—Etoposide—brain cancer	8.8e-05	0.000657	CcSEcCtD
Cladribine—POLE2—Cell Cycle, Mitotic—PCNA—brain cancer	8.78e-05	0.000947	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	8.74e-05	0.000943	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	8.72e-05	0.000941	CbGpPWpGaD
Cladribine—Pruritus—Etoposide—brain cancer	8.68e-05	0.000648	CcSEcCtD
Cladribine—POLE—Mitotic G1-G1/S phases—CCND1—brain cancer	8.61e-05	0.000929	CbGpPWpGaD
Cladribine—RRM2—G1/S Transition—MYC—brain cancer	8.54e-05	0.000921	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—SKP2—brain cancer	8.51e-05	0.000918	CbGpPWpGaD
Cladribine—PNP—Metabolism—ENO2—brain cancer	8.49e-05	0.000916	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDK6—brain cancer	8.48e-05	0.000915	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CYP2C9—brain cancer	8.44e-05	0.00091	CbGpPWpGaD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—TP53—brain cancer	8.4e-05	0.000906	CbGpPWpGaD
Cladribine—Diarrhoea—Etoposide—brain cancer	8.39e-05	0.000627	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	8.33e-05	0.000898	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	8.26e-05	0.00089	CbGpPWpGaD
Cladribine—POLE—G1/S Transition—MYC—brain cancer	8.2e-05	0.000884	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	8.18e-05	0.000882	CbGpPWpGaD
Cladribine—Dizziness—Etoposide—brain cancer	8.11e-05	0.000606	CcSEcCtD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—TP53—brain cancer	8.06e-05	0.00087	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—MYC—brain cancer	8.05e-05	0.000868	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDK6—brain cancer	7.9e-05	0.000852	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—PCNA—brain cancer	7.85e-05	0.000847	CbGpPWpGaD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—TP53—brain cancer	7.85e-05	0.000847	CbGpPWpGaD
Cladribine—Vomiting—Etoposide—brain cancer	7.8e-05	0.000582	CcSEcCtD
Cladribine—NR5A1—Developmental Biology—CDK4—brain cancer	7.74e-05	0.000834	CbGpPWpGaD
Cladribine—Rash—Etoposide—brain cancer	7.73e-05	0.000577	CcSEcCtD
Cladribine—Dermatitis—Etoposide—brain cancer	7.73e-05	0.000577	CcSEcCtD
Cladribine—Headache—Etoposide—brain cancer	7.68e-05	0.000574	CcSEcCtD
Cladribine—POLE2—Cell Cycle, Mitotic—CDK4—brain cancer	7.59e-05	0.000819	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDK6—brain cancer	7.59e-05	0.000818	CbGpPWpGaD
Cladribine—POLE—S Phase—MYC—brain cancer	7.44e-05	0.000803	CbGpPWpGaD
Cladribine—Nausea—Etoposide—brain cancer	7.29e-05	0.000544	CcSEcCtD
Cladribine—POLA1—Mitotic G1-G1/S phases—CDKN2A—brain cancer	7.27e-05	0.000783	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—DNMT1—brain cancer	7.24e-05	0.00078	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	7.2e-05	0.000776	CbGpPWpGaD
Cladribine—RRM2—Mitotic G1-G1/S phases—MYC—brain cancer	7.2e-05	0.000776	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	7.2e-05	0.000776	CbGpPWpGaD
Cladribine—RRM1—Metabolism—BSG—brain cancer	7.18e-05	0.000774	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—MYC—brain cancer	7e-05	0.000754	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP2C9—brain cancer	6.95e-05	0.00075	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—MYC—brain cancer	6.91e-05	0.000745	CbGpPWpGaD
Cladribine—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	6.82e-05	0.000736	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDK4—brain cancer	6.79e-05	0.000732	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—SKP2—brain cancer	6.78e-05	0.000731	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	6.78e-05	0.000731	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	6.7e-05	0.000722	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CCNE1—brain cancer	6.66e-05	0.000718	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—S100A10—brain cancer	6.63e-05	0.000715	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.62e-05	0.000714	CbGpPWpGaD
Cladribine—POLA1—S Phase—CCND1—brain cancer	6.61e-05	0.000713	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—ESR2—brain cancer	6.5e-05	0.0007	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP2C9—brain cancer	6.5e-05	0.0007	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.48e-05	0.000698	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CCNE1—brain cancer	6.39e-05	0.000689	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—S100A10—brain cancer	6.18e-05	0.000666	CbGpPWpGaD
Cladribine—RRM1—Metabolism—IDH1—brain cancer	6.17e-05	0.000665	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—NOTCH2—brain cancer	6.15e-05	0.000663	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—BRCA2—brain cancer	6.15e-05	0.000663	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—CCND1—brain cancer	6.14e-05	0.000662	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—SKP2—brain cancer	6.06e-05	0.000654	CbGpPWpGaD
Cladribine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	6.06e-05	0.000653	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDK6—brain cancer	6.04e-05	0.000652	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CCNE1—brain cancer	5.95e-05	0.000642	CbGpPWpGaD
Cladribine—RRM2—Metabolism—BSG—brain cancer	5.91e-05	0.000637	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—BRCA2—brain cancer	5.9e-05	0.000636	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—PCNA—brain cancer	5.9e-05	0.000636	CbGpPWpGaD
Cladribine—POLA1—G1/S Transition—MYC—brain cancer	5.84e-05	0.00063	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—CDKN2A—brain cancer	5.8e-05	0.000626	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—TP53—brain cancer	5.75e-05	0.00062	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CCNE1—brain cancer	5.71e-05	0.000616	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—RELA—brain cancer	5.69e-05	0.000613	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—PCNA—brain cancer	5.66e-05	0.00061	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—ERBB2—brain cancer	5.65e-05	0.00061	CbGpPWpGaD
Cladribine—DCK—Metabolism—BSG—brain cancer	5.52e-05	0.000596	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.44e-05	0.000586	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDK6—brain cancer	5.4e-05	0.000583	CbGpPWpGaD
Cladribine—POLA1—S Phase—MYC—brain cancer	5.3e-05	0.000572	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—PCNA—brain cancer	5.27e-05	0.000568	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.26e-05	0.000568	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—SIRT1—brain cancer	5.23e-05	0.000564	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDKN2A—brain cancer	5.19e-05	0.000559	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	5.19e-05	0.000559	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDK4—brain cancer	5.1e-05	0.00055	CbGpPWpGaD
Cladribine—RRM2—Metabolism—IDH1—brain cancer	5.08e-05	0.000548	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—PCNA—brain cancer	5.06e-05	0.000546	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—CTNNB1—brain cancer	4.95e-05	0.000533	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—MYC—brain cancer	4.92e-05	0.000531	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—CCND1—brain cancer	4.9e-05	0.000529	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDK4—brain cancer	4.89e-05	0.000528	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ENO2—brain cancer	4.88e-05	0.000526	CbGpPWpGaD
Cladribine—DCK—Metabolism—IDH1—brain cancer	4.75e-05	0.000512	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.65e-05	0.000501	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.61e-05	0.000497	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDK4—brain cancer	4.56e-05	0.000491	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CCNE1—brain cancer	4.55e-05	0.000491	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PIK3CG—brain cancer	4.49e-05	0.000485	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CCND1—brain cancer	4.38e-05	0.000473	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDK4—brain cancer	4.37e-05	0.000472	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—VEGFA—brain cancer	4.35e-05	0.00047	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—STAT3—brain cancer	4.31e-05	0.000465	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—MYC—brain cancer	4.26e-05	0.000459	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—BRCA2—brain cancer	4.2e-05	0.000453	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CCNE1—brain cancer	4.07e-05	0.000439	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.05e-05	0.000437	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—PCNA—brain cancer	4.03e-05	0.000435	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ENO2—brain cancer	4.02e-05	0.000433	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—MYC—brain cancer	3.93e-05	0.000424	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—EGFR—brain cancer	3.92e-05	0.000423	CbGpPWpGaD
Cladribine—PNP—Metabolism—PIK3CG—brain cancer	3.9e-05	0.00042	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN2A—brain cancer	3.9e-05	0.00042	CbGpPWpGaD
Cladribine—DCK—Metabolism—ENO2—brain cancer	3.75e-05	0.000405	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN2A—brain cancer	3.74e-05	0.000403	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.73e-05	0.000402	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.65e-05	0.000393	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—PCNA—brain cancer	3.61e-05	0.000389	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—MYC—brain cancer	3.52e-05	0.000379	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDK4—brain cancer	3.49e-05	0.000376	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN2A—brain cancer	3.48e-05	0.000376	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN2A—brain cancer	3.34e-05	0.000361	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CCND1—brain cancer	3.29e-05	0.000355	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CCND1—brain cancer	3.16e-05	0.000341	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDK4—brain cancer	3.12e-05	0.000336	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.09e-05	0.000334	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.06e-05	0.00033	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.06e-05	0.00033	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CCND1—brain cancer	2.94e-05	0.000317	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—TP53—brain cancer	2.89e-05	0.000311	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.85e-05	0.000308	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CCND1—brain cancer	2.83e-05	0.000305	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN2A—brain cancer	2.66e-05	0.000287	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—MYC—brain cancer	2.64e-05	0.000285	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP2C9—brain cancer	2.6e-05	0.00028	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP2C9—brain cancer	2.57e-05	0.000277	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—MYC—brain cancer	2.53e-05	0.000273	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP2C9—brain cancer	2.4e-05	0.000259	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN2A—brain cancer	2.38e-05	0.000257	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—MYC—brain cancer	2.36e-05	0.000255	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MYC—brain cancer	2.27e-05	0.000244	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CCND1—brain cancer	2.25e-05	0.000243	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CG—brain cancer	2.24e-05	0.000241	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—BSG—brain cancer	2.21e-05	0.000238	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—BSG—brain cancer	2.19e-05	0.000236	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—MYC—brain cancer	2.05e-05	0.000221	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—BSG—brain cancer	2.04e-05	0.00022	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CCND1—brain cancer	2.01e-05	0.000217	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—TP53—brain cancer	1.94e-05	0.000209	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—IDH1—brain cancer	1.9e-05	0.000205	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—IDH1—brain cancer	1.88e-05	0.000203	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TP53—brain cancer	1.86e-05	0.000201	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CG—brain cancer	1.84e-05	0.000199	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—MYC—brain cancer	1.81e-05	0.000195	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—IDH1—brain cancer	1.75e-05	0.000189	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CG—brain cancer	1.72e-05	0.000186	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MYC—brain cancer	1.61e-05	0.000174	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ENO2—brain cancer	1.5e-05	0.000162	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ENO2—brain cancer	1.49e-05	0.00016	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ENO2—brain cancer	1.39e-05	0.000149	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TP53—brain cancer	1.33e-05	0.000143	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CG—brain cancer	6.89e-06	7.43e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CG—brain cancer	6.82e-06	7.36e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CG—brain cancer	6.36e-06	6.86e-05	CbGpPWpGaD
